Gilead Sciences Inc. (GILD): Price and Financial Metrics

GILD POWR Grades

• Value is the dimension where GILD ranks best; there it ranks ahead of 99.29% of US stocks.
• GILD's strongest trending metric is Sentiment; it's been moving down over the last 179 days.
• GILD ranks lowest in Momentum; there it ranks in the 4th percentile.

GILD Stock Summary

• GILD has a market capitalization of $75,897,763,404 -- more than approximately 96.5% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, Gilead Sciences Inc is reporting a growth rate of 246.22%; that's higher than 91.47% of US stocks.
• Gilead Sciences Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 11.51%, greater than the shareholder yield of 85.92% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Gilead Sciences Inc are KLAC, ADI, EW, NTES, and ON.
• GILD's SEC filings can be seen here. And to visit Gilead Sciences Inc's official web site, go to www.gilead.com.

GILD Valuation Summary

• GILD's price/sales ratio is 3.4; this is 10.53% lower than that of the median Healthcare stock.
• GILD's price/sales ratio has moved down 24.1 over the prior 243 months.
• Over the past 243 months, GILD's price/sales ratio has gone down 24.1.

Below are key valuation metrics over time for GILD.

GILD Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -50.73%.
• Its 5 year net cashflow from operations growth rate is now at -50.73%.
• The 2 year cash and equivalents growth rate now stands at 31.51%.

GILD's revenue has moved up $4,985,000,000 over the prior 34 months.

The table below shows GILD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	27,305	11,384	6,225
2021-09-30	27,482	10,095	7,394
2021-06-30	26,638	9,092	5,162
2021-03-31	25,564	9,342	301
2020-12-31	24,689	8,168	123
2020-09-30	23,147	8,832	1,268

GILD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GILD has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• GILD's asset turnover comes in at 0.406 -- ranking 114th of 682 Pharmaceutical Products stocks.
• ENTA, RDUS, and ADMS are the stocks whose asset turnover ratios are most correlated with GILD.

The table below shows GILD's key quality metrics over time.